Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-25 Purchase | 2025-08-25 7:01 pm | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 2,000 | $2.55 | $5,100 | 482,788 (Direct) | View |
| 2024-12-19 Purchase | 2024-12-20 08:30 am | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 1,000 | $4.83 | $4,830 | 344,960 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-22 08:04 am | Motus GI Holdings Inc. | MOTS | Taylor Andrew Lawrence Chief Financial Officer | 2,000 | $0.5106 | $1,021 | 135,682 (Direct) | View |
| 2020-12-09 Purchase | 2020-12-10 09:02 am | Motus GI Holdings Inc. | MOTS | Taylor Andrew Lawrence Chief Financial Officer | 1,000 | $1.08 | $1,080 | 73,682 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-25 Tax Withholding | 2025-11-26 4:05 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 3,071 | $5.35 | 463,615 (Direct) | View |
| 2025-09-17 Tax Withholding | 2025-09-19 5:30 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 16,102 | $2.46 | 466,686 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-08 7:18 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 80,000 | $0 | 480,788 (Direct) | View |
| 2025-06-11 Tax Withholding | 2025-06-13 4:43 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 28,172 | $3.14 | 400,788 (Direct) | View |
| 2025-04-04 Option Award | 2025-04-04 9:37 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 84,000 | $0 | 428,960 (Direct) | View |
| 2024-12-12 Tax Withholding | 2024-12-13 4:15 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 34,403 | $5.03 | 343,960 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 5:18 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 100,000 | $0 | 378,363 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-24 5:12 pm | N/A N/A | Orchestra BioMed Holdings Inc. | OBIO | Taylor Andrew Lawrence Chief Financial Officer | 278,363 | $0 | 278,363 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-11 5:15 pm | N/A 2032-02-10 | Motus GI Holdings Inc. | MOTS | Taylor Andrew Lawrence Chief Financial Officer | 95,000 | $0 | 325,682 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:15 pm | N/A 2031-02-17 | Motus GI Holdings Inc. | MOTS | Taylor Andrew Lawrence Chief Financial Officer | 60,000 | $0 | 193,682 (Direct) | View |